PJ Anand

PJ Anand is an accomplished entrepreneur and executive with extensive experience in the biomedical field. As the Founder, President, and CEO of Alcyone Therapeutics, Inc. since January 2010, PJ Anand has focused on pioneering next-generation precision CNS genetic therapies. Additionally, as the Founder and Board Member of Anuncia Inc. since February 2018, PJ Anand is dedicated to developing improved treatments for Hydrocephalus and Cerebrospinal fluid dysfunctions. Since January 2012, PJ Anand has served as Co-founder and Executive Chairman of Arthromeda, Inc., a company specializing in patient-specific implant positioning technology for joint replacement procedures. Previously, PJ Anand held the position of Executive Vice President of Corporate Development at Arsenal Medical, Inc. from January 2006 to November 2010 and served as Vice President & General Manager at Spire Biomedical, Inc. from February 2000 to January 2006.